StockFame
  • Trending News
  • Markets
  • US Markets
  • Indian Stocks
  • Economics
  • Crypto News
Select Page

Dr Reddy’s Wins Canada Approval For Generic Ozempic, Price War Looms To Make GLP-1 Affordable

by NDTV Profits | April 29, 2026 8:29 am | Latest Posts, Market, Trending News

Globally, competition is already intensifying. In some markets, generic semaglutide is expected to bring monthly treatment costs down to as little as $14

Recent Posts

  • ETMarkets PMS Talk | Outperforming in a Crash: How Qode Growth Fund beat its benchmark by 14%, explains Rishabh Nahar
  • Taiwan overtakes Canada to become 6th largest stock market as AI demand lifts TSMC m-cap to $1.8 trillion
  • Pfizer among 6 stocks showing bullish RSI upswing
  • Negative Breakout: These 7 stocks closed below their 200 DMA
  • Stocks to buy in 2026 for long term: Varun Beverages, Sun Pharma among 5 stocks that could give 10-20% return

About Stockfame

Stockfame is a global media platform delivering bold insights on business, markets, technology, leadership, and entrepreneurship. We bring you research-backed news and sharp analysis to help you stay ahead of the curve.

Quick News Links

  • Crypto News
  • Indian Stocks
  • Latest Posts
  • Market
  • News
  • Trending News
  • US Markets

Contact Us

Reach out to us at:
Phone:  [+91] 9834938257
Email: contact@stockfame.com
For Advertisement, Press Releases, Partnerships or to get backlinks on this website, please e-mail us at contact@stockfame.com

Quick Reads

  • Global market news
  • Crypto Market News
  • Indian Market News
  • Economy News
  • Latest Business News
  • About
  • Terms and Conditions
  • Privacy Policy
  • Website User Agreement
  • Disclaimer
  • Facebook
  • X
  • Instagram
  • RSS
Copyright @StockFame | All Rights Reserved